HC Wainwright & Co. Reiterates Arbutus Biopharma (ABUS) Buy Recommendation
- Stock Market Stocks to buy Stocks to sell
admin
- 0
- 1 minute read
Fintel reports that on April 28, 2023, HC Wainwright & Co. reiterated coverage of Arbutus Biopharma (NASDAQ:ABUS) with a Buy recommendation. Analyst Price Forecast Suggests 130.28% Upside
:max_bytes(150000):strip_icc():format(jpeg)/PropertyValuation-4ecdfe3a87144fe998087ef433f49c13.jpeg "Is There a Gender Gap in Home Equity Loans?")
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-1346781100-2724c28da6b2479b88db9d1337ebe926.jpg "Buy Now, Pay Later or Rent-to-Own: Which Is the Smarter Way to Pay for Purchases?")